MedPath

Feasibility study of Carboplatin plus Pemetrexed in patients with recurrent and postoperative non-small cell lung cancer

Phase 1
Conditions
non small and non squamous lung cancer
Registration Number
JPRN-UMIN000004866
Lead Sponsor
Department of Thoracic Surgery, University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1.Interstitial pneumonia or pulmonary fibrosis on Chest Xray 2.Unstable pleural effusion formation 3.Superior vena cava syndrome 4.Uncotrolled diabetes mellitus, hypertension, liver dysfunction, angina pectoris, and acute myocardial infarction 5.Severe infection, a sign of severe infection 6.Grade2 or worse peripheral nerve disorder at the time of enrollment 7.Regular user of NSAIDs 8.Pregnant woman, lactating woman, woman of child-bearing potential, woman who wish to pregnancy 9.Severe drug allergy 10.Severe complication 11Other inadequate reasons 12.New lesion that is recognized before enrollment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath